missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ TFAP2E Polyclonal Antibody

Goat Polyclonal Antibody
Marke: Invitrogen™ PA5148949
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
Reconstitute at 0.2 mg/mL in sterile PBS.
TFAP2E is the sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2 epsilon may play a role in the development of the CNS and in cartilage differentiation.
Spezifikation
| TFAP2E | |
| Polyclonal | |
| Unconjugated | |
| TFAP2E | |
| activating enhancer-binding protein 2 epsilon; activating enhancer-binding protein 2-epsilon; adaptor-related protein complex 2, epsilon subunit; AI505200; AP2E; AP-2e; AP-2-epsilon; AP2-epsilon; hypothetical protein MGC65882; LOW QUALITY PROTEIN: transcription factor AP-2-epsilon; MGC49007; RGD1563297; Tcfap2e; Tfap2e; transcription factor AP-2 epsilon; transcription factor AP-2 epsilon (activating enhancer binding protein 2 epsilon); transcription factor AP-2, epsilon; transcription factor AP-2-epsilon; zgc:65882; zgc:65882 protein; zgc:77338 | |
| Goat | |
| Antigen affinity chromatography | |
| RUO | |
| 339488 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Lyophilized |
| Western Blot | |
| 0.2 mg/mL | |
| PBS with trehalose and no preservative | |
| Q6VUC0 | |
| TFAP2E | |
| E. coli-derived recombinant human AP-2 epsilon , Ala123-Val217. | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur